Feedback / Questions
cendakimab (CC-93538) - AbbVie, BMS
lebrikizumab (LY3650150) - Roche, Almirall, Eli Lilly
Adbry (tralokinumab) - LEO Pharma, AstraZeneca
eblasakimab (ASLAN004) - ASLAN Pharma
http://www.ncbi.nlm.nih.gov/pubmed/36839890
Feb 25, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next